Grants per year
Search results
-
Active
-
Prot #VLX-601: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients with Primary Biliary Cholangitis (VANTAGE)
Boike, J. R. (PD/PI)
Premier Research International, LLC, Mirum Pharmaceuticals
11/16/22 → 11/16/25
Project: Research project
-
Prot #CM-101-PSC-101: A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial Evaluating the Safety and Efficacy of CM-101 in Subjects with Primary Sclerosing Cholangitis - The Spring Study
Boike, J. R. (PD/PI)
Covance Inc., Chemomab Therapeutics Ltd.
7/19/22 → 7/19/25
Project: Research project
-
Cognitive Function, Self-Management, and Health Outcomes among Liver Transplant Recipients: the LivCog Cohort
Wolf, M. (PD/PI), Yoshino Benavente, J. N. (PD/PI), Yoshino Benavente, J. N. (PD/PI), Boike, J. R. (Co-Investigator), Boike, J. R. (Co-Investigator), Gershon, R. (Co-Investigator), Gershon, R. (Co-Investigator), Kim, M. (Co-Investigator) & Kim, M. (Co-Investigator)
University of Pennsylvania, National Institute of Diabetes and Digestive and Kidney Diseases
5/4/22 → 2/28/27
Project: Research project
-
Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression
Levitsky, J. (PD/PI), Levitsky, J. (PD/PI), Boike, J. R. (Co-Investigator), Boike, J. R. (Co-Investigator), Carr, J. (Co-Investigator), Carr, J. (Co-Investigator), Forte, E. (Co-Investigator), Forte, E. (Co-Investigator), Forte, E. (Co-Investigator), Goo, Y. A. (Co-Investigator), Goo, Y. A. (Co-Investigator), Kelleher, N. L. (Co-Investigator), Kelleher, N. L. (Co-Investigator), Srivastava, A. (Co-Investigator), Srivastava, A. (Co-Investigator), Srivastava, A. (Co-Investigator), Tambur, A. R. (Co-Investigator), Tambur, A. R. (Co-Investigator), Zhao, L. (Co-Investigator) & Zhao, L. (Co-Investigator)
National Institute of Allergy and Infectious Diseases
9/6/21 → 6/30/28
Project: Research project
-
Finished
Prot# MGL-3196-11: A Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 (resmetirom) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis to Resolve NASH and Reduce Progression to Cirrhosis and/or Hepatic
Boike, J. R. (PD/PI)
Pharmaceutical Research Associates, Inc., Synta Pharmaceuticals Corp.
12/20/19 → 12/31/24
Project: Research project